Search for a trial

A Phase I randomised, double-blind, 2-way cross-over study to compare the peripheral vasodilatation following treatment with DRL 21994 or NIASPAN® and to determine the pharmacokinetics of DRL 21994 in healthy, adult male subjects under fed conditions.

The aim of the study is twofold. The first is the impact of DRL-21994 and the registered product on the release of vessels studied and compared. The second is the speed with which DRL-21994 is included in the body examined, as well as the degree of…

A Phase I, Randomised, Double-Blind, 3-Way Cross-Over Study to Compare the Safety, Tolerability, Pharmacokinetics and Vasodilatory Effect of DRL-21995, DRL 21994 and Niaspan® in Healthy, Adult Male Subjects under Fed Conditions

The aim of the study is twofold. The first is the impact of the investigational drugs and the registered product on safety, tolerability and the release of vessels studied and compared. The second is the speed with which the investigational drugs…